Drug intelligence / Profile preview

dexproxibutene hemimaleate

Development stage
Discontinued
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Dexproxibutene hemimaleate (CIBA-44328) is a synthetic analgesic compound structurally related to dextropropoxyphene. It is the dextrorotary isomer of 2-(dimethylaminomethyl)-1,2-diphenyl-3-butene-2-ol proprionate in the maleate form. The drug was investigated as an oral analgesic for pain management in conditions such as rheumatoid arthritis and demonstrated intermediate efficacy between paracetamol and stronger agents like aspirin or codeine combinations. Its mechanism of action is presumed to be similar to other diphenylbutylamine derivatives (like dextropropoxyphene), acting primarily as a central nervous system depressant with opioid-like properties[6][7].

Other names
dexproxibutene maleateD-1,2-diphenyl-2-propionyloxy-3-(dimethylaminomethyl)-3-butene maleate
02

Targets

MOR (Mu opioid receptor)

Beyond the preview

Go deeper on dexproxibutene hemimaleate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexproxibutene hemimaleate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call